MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Medline Inc.
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 5, 2026
$35.19−0.77 (-2.14%)
Close on Oct 19, 2026
- Market cap
- $30.29B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$6.46 (−15.51%)since Dec 19, 2025
Weekly closes, adjusted for splits, on a log scale. Drag across the chart to measure a change.
Medline Inc. grew revenue 11.5% to $28.43B over fiscal 2025. Operating income rose 3.1% to $2.21B, moving the operating margin from 8.4% to 7.8%. Free cash flow was $1.30B, down 8.3% from a year earlier.
Revenue
$28.43B
+11.5% vs. a year earlier
Operating income
$2.21B
+3.1% vs. a year earlier
Free cash flow
$1.30B
-8.3% vs. a year earlier
EPS, diluted
-$0.01
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 27, 2026
Valuation
- Market cap
- $30.29B
- P/E ratio
- –
- Price to sales
- 1.07
- Price to book
- 2.62
- Dividend yield
- –
- Free cash flow yield
- 4.28%
Fundamentals
- Revenue
- $28.43B
- Net income
- $1.16B
- EPS, diluted
- -$0.01
- Free cash flow
- $1.30B
- Book value per share
- $13.44
- Diluted shares
- 861M
Four years at a glance
Fiscal years 2022 to 2025, USD
Revenue
$28.43B+11.5% YoY
Gross profit
$7.52B+7.8% YoY
Operating income
$2.21B+3.1% YoY
Net income
$1.16B
EPS, diluted
-$0.01
Free cash flow
$1.30B-8.3% YoY
Reported period